Healthcare provider profile · identity verified

Edward P Stein, MD

Family Practice · EUREKA, MT · NPI 1063465938

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	483	83
Lisinopril	Lisinopril	410	74
Levothyroxine Sodium	Levothyroxine Sodium	341	49
Omeprazole	Omeprazole	270	56
Amlodipine Besylate	Amlodipine Besylate	262	48
Rosuvastatin Calcium	Rosuvastatin Calcium	248	49
Tamsulosin Hcl	Tamsulosin Hcl	236	51
Eliquis	Apixaban	211	26
Losartan Potassium	Losartan Potassium	198	39
Gabapentin	Gabapentin	195	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	190	41
Potassium Chloride	Potassium Chloride	186	34
Metoprolol Tartrate	Metoprolol Tartrate	174	31
Metformin Hcl	Metformin Hcl	165	28
Escitalopram Oxalate	Escitalopram Oxalate	148	21
Divalproex Sodium	Divalproex Sodium	146	13
Allopurinol	Allopurinol	144	28
Hydrochlorothiazide	Hydrochlorothiazide	136	25
Metoprolol Succinate	Metoprolol Succinate	130	29
Furosemide	Furosemide	124	26
Warfarin Sodium	Warfarin Sodium	108	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	105	18
Prednisone	Prednisone	105	32
Citalopram Hbr	Citalopram Hydrobromide	100	14
Clopidogrel	Clopidogrel Bisulfate	98	18
Duloxetine Hcl	Duloxetine Hcl	97	16
Metformin Hcl Er	Metformin Hcl	93	20
Meloxicam	Meloxicam	87	21
Alprazolam	Alprazolam	79	17
Simvastatin	Simvastatin	75	17
Trazodone Hcl	Trazodone Hcl	75	16
Lorazepam	Lorazepam	68	16
Tramadol Hcl	Tramadol Hcl	60	13
Carvedilol	Carvedilol	59	11
Alendronate Sodium	Alendronate Sodium	58	17
Albuterol Sulfate Hfa	Albuterol Sulfate	53	22
Azithromycin	Azithromycin	47	39
Zolpidem Tartrate	Zolpidem Tartrate	46	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	43	22
Januvia	Sitagliptin Phosphate	41	suppressed
Jardiance	Empagliflozin	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	16
Mirtazapine	Mirtazapine	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Famotidine	Famotidine	32	suppressed
Atenolol	Atenolol	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	15
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Glimepiride	Glimepiride	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Nystatin	Nystatin	30	21
Benazepril Hcl	Benazepril Hcl	29	suppressed
Sertraline Hcl	Sertraline Hcl	29	suppressed
Cephalexin	Cephalexin	27	25
Clobetasol Propionate	Clobetasol Propionate	27	suppressed
Digoxin	Digoxin	27	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Xarelto	Rivaroxaban	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Torsemide	Torsemide	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	15
Donepezil Hcl	Donepezil Hcl	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Nitroglycerin	Nitroglycerin	21	17
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Ozempic	Semaglutide	21	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Methylprednisolone	Methylprednisolone	18	11
Baclofen	Baclofen	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	11
Levetiracetam	Levetiracetam	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Amoxicillin	Amoxicillin	15	11
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Dexamethasone	Dexamethasone	15	15
Finasteride	Finasteride	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Triazolam	Triazolam	13	suppressed
Acebutolol Hcl	Acebutolol Hcl	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Insulin Degludec Pen (U-200)	Insulin Degludec	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Naloxone Hcl	Naloxone Hcl	11	11
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error